Sulindac can cause developmental toxicity and female reproductive toxicity according to state or federal government labeling requirements.
定義
米国FDA 物質登録 · UNII 184SNS8VUH · 登録名 Sulindac · 単一の化学物質
Sulindac can cause developmental toxicity and female reproductive toxicity according to state or federal government labeling requirements.
出典: PubChem
化粧品での役割
酸素による劣化を遅らせるANTIOXIDANT
安全性・規制情報
韓国の有害物質GHS分類なし · 既存化学物質
詳しい資料 — 表示名・識別番号・物性・試験記録・文献
別名・識別情報
SULINDACINCI
- CAS No.化学物質登録番号
- 38194-50-2
- EC No.EU化学物質目録番号
- 253-819-2
- DTXSID米国EPA化学物質番号
- DTXSID4023624
- DTXCID米国EPA化合物番号
- DTXCID703624
- IUPAC
- [(1E)-5-Fluoro-1-{[4-(methanesulfinyl)phenyl]methylidene}-2-methyl-1H-inden-3-yl]acetic acid
- 分子式
- C20H17FO3S
- 分子量
- 356.41 g/mol
製品が実際に使っている用途
関連文献
- Topical sulindac combined with hydrogen peroxide in the treatment of actinic keratoses. · 2009
- Chemoprevention effects of a sulindac-based compound on TPA-induced skin inflammation in mice · 2015
- Sulindac sulfide inhibits colon cancer cell growth and downregulates specificity protein transcription factors · 2015
- Sulindac Metabolites Induce Proteosomal and Lysosomal Degradation of the Epidermal Growth Factor Receptor · 2010
- Effect of Naproxen and Sulindac on Blood Pressure Response to Atenolol · 1990